10-K: Bowhead Specialty Holdings Inc. Reports Fiscal Year 2024 Results, Highlights Growth and Strategic Initiatives

Sentiment:

Annual Results 27 February 2025 5:14 PM

📋All filings for Bowhead Specialty Holdings INC

Bowhead Specialty Holdings Inc. announces its financial results for the fiscal year ended December 31, 2024, showcasing growth in gross written premiums and strategic expansion.

Capital raiseOn May 22, 2024, the Board approved the issuance of warrants to AFMIC, a related party of the Company, to purchase shares of the Companys common stock.On May 28, 2024, the Company issued to AFMIC warrants to purchase additional shares of the Companys common stock.On May 23, 2024, the Company completed an upsized initial public offering (the IPO) with the sale of 8,658,823 shares of common stock at a price to the public of $17.00 per share.After underwriter discounts, commissions and offering expenses, net proceeds to the Company from the IPO were approximately $131.0 million.

Worse than expectedReturn on equity was worse than expected due to the $178.4 million increase in mezzanine equity and stockholders equity, mainly due to the $131.0 million of net proceeds received from the IPO and $38.2 million of net income generated during the year, and a $7.3 million reduction in after tax net income as a result of the costs related to the IPO and Secondary Offering.

Summary

Bowhead Specialty Holdings Inc. (BOW) reported its financial results for the fiscal year ended December 31, 2024.
Gross written premiums increased by 37.0% to $695.7 million, driven by renewals, new business, and growth across all four underwriting divisions.
Net written premiums rose by 34.9% to $451.4 million.
Net earned premiums increased by 45.9% to $385.1 million.
The loss ratio was 64.4%, a 1.4 point increase compared to the previous year, attributed to portfolio mix changes.
The expense ratio decreased by 0.5 points to 31.4%, driven by scaling the business and prudent expense management.
The combined ratio was 95.8%, a 0.9 point increase from the previous year.
Net investment income more than doubled, increasing by 107.1% to $40.1 million.
Net income increased by 52.7% to $38.2 million.
Return on equity was 13.6%, a decrease from the previous year due to increased equity and IPO-related costs.
The company has a $75 million revolving credit facility, with no outstanding borrowings as of December 31, 2024.
The company is subject to insurance regulations, including risk-based capital requirements and dividend restrictions.
The company is focused on attracting and retaining best-in-class talent, profitably growing existing lines of business, and strategically expanding into new products and markets.

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While there is strong growth in premiums and investment income, there are also concerns about the loss ratio, return on equity, and competitive pressures. The company's strategic initiatives and experienced leadership team are positive factors.

Positives

Significant growth in gross written premiums, net earned premiums, and net investment income.
Decrease in the expense ratio, indicating improved operational efficiency.
Strong balance sheet with a diversified investment portfolio.
Strategic partnership with AmFam provides access to licenses and capital.
Experienced and entrepreneurial leadership team.
Remote-friendly operating model allows for attracting top talent nationwide.
Proprietary underwriting tools (BRATs) enhance efficiency and accuracy.
The company has never had an allowance for uncollectible reinsurance.

Negatives

Increase in the loss ratio, driven by portfolio mix changes.
Decrease in return on equity due to increased equity and IPO-related costs.
Dependence on a strategic relationship with AmFam.
The commercial specialty P&C insurance industry is highly competitive.

Risks

Inaccurate assessment of underwriting risk could adversely affect financial results.
Intense competition in the commercial specialty P&C insurance industry.
Inability to maintain the strategic relationship with AmFam.
A decline in AmFams financial strength rating or financial size category.
Reliance on insurance retail agents, brokers, and wholesalers.
Inadequate losses and loss expense reserves.
Reinsurers may not reimburse claims on a timely basis, or at all.
Adverse economic factors could impact growth and profitability.
Extensive regulation may affect the ability to achieve business objectives.
Security breaches, loss of data, cyberattacks, and other information technology failures.
Increased costs as a result of operating as a public company.

Future Outlook

The company expects to capitalize on the broader market opportunity and expand its market share to generate strong underwriting results. The company also intends to deliver attractive underwriting results, overall profitability and returns to its stockholders through underwriting expertise and disciplined risk management, supported by a conservative investment strategy, legacy-free reserves and prudent approach to capital deployment.

Management Comments

The company's principal objective is to create and sustain superior returns for its stockholders by generating consistent, underwriting profits across its product offerings and through all market cycles, while prudently managing capital.
The company believes that its current market opportunity, differentiated expertise, relationships, culture and leadership team position it well to continue to grow its business profitably.

Industry Context

The commercial specialty P&C insurance industry is highly competitive and cyclical. The company competes with domestic and international insurers, MGAs, and program administrators. The company primarily operates in the $83.3 billion U.S. commercial E&S market.

Comparison to Industry Standards

The company competes with American International Group, Inc., Arch Capital Group Ltd., AXA S.A., AXIS Capital Holdings Ltd., Berkshire Hathaway Corporation, C.V. Starr & Co., Inc., Chubb Ltd., Cincinnati Financial Corporation, CNA Financial Corporation, Liberty Mutual Insurance Company, Nationwide Mutual Insurance Company, The Doctors Company, The Travelers Companies, Inc. and W.R. Berkley Corporation.
The company primarily operates in the $83.3 billion U.S. commercial E&S market (for the year ended December 31, 2023) that has grown 20.9% annually since 2019.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Appointment	Dr. Ava Schnidman was elected to the board of directors and appointed to the Compensation, Nominating and Corporate Governance Committee on October 30, 2024.	October 30, 2024	Increased independence of the Compensation, Nominating and Corporate Governance Committee.
Adoption of Clawback Policy	The Board of Directors adopted the Clawback Policy to be applied to the Executive Officers of the Company.	May 22, 2024	The Policy is intended to satisfy the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as it may be amended from time to time, and any related rules or regulations promulgated by the SEC or the NYSE.
Adoption of Change in Control Severance Plan	The Board approved and adopted the Bowhead Specialty Holding Inc. Change in Control Severance Plan.	February 21, 2025	The Plan and Summary Plan Description, as set forth herein, is intended to, among other things, help retain qualified fulland part-time regular employees, maintain a stable work environment and provide economic security to Participants in the event of certain terminations of employment.

Legal Proceedings

The company is subject to routine legal proceedings in the normal course of operating its insurance business.

Related Party Transactions

AmFam beneficially owns approximately 14.4% of BSHIs issued and outstanding common stock as of December 31, 2024.
BICI is party to the AmFam Quota Share Agreement, which has been effective since 2020.
Under the MGA Agreements, BSUI is permitted to issue insurance policies on behalf of the AmFam Issuing Carriers and is also responsible for providing accounting, claims handling and other necessary services to the AmFam Issuing Carriers to support its respective regulatory, statutory and other compliance requirements.
In 2024, 2023 and 2022, BICI entered into a ceded quota share reinsurance treaty and a ceded excess of loss reinsurance agreement with reinsurers, in which a separate subsidiary of AmFam participated.
On May 22, 2024, the Board approved the issuance of warrants to AFMIC, a related party of the Company, to purchase shares of the Companys common stock.

Stakeholder Impact

The company's performance impacts shareholders through stock value and potential dividends.
Employees are affected by compensation, benefits, and job security.
Policyholders rely on the company's ability to pay claims.
Brokers and agents depend on the company for competitive products and services.
Reinsurers are impacted by the company's risk management practices.

Next Steps

The company will continue to focus on attracting and retaining best-in-class talent.
The company will continue to focus on profitably growing existing lines of business.
The company will continue to focus on opportunistically and strategically expanding into new products and markets.
The company will continue to leverage expertise, technology, data and analytics to drive underwriting performance.
The company will continue to deliver attractive returns on capital to its stockholders.

Key Dates

Date	Description
September 2020	Company founded.
December 18, 2020	BICI received Certificate of Authority from Wisconsin Office of the Commissioner of Insurance.
July 21, 2011	The Nonadmitted and Reinsurance Reform Act of 2010 (NRRA) became effective.
October 24, 2017	The NAIC adopted its Insurance Data Security Model Law.
December 2020	The NAIC adopted a group capital calculation tool (GCC).
January 2022	A court in New Jersey denied the applicability of war exclusions with respect to nation-state-led cyber attacks.
May 9, 2024	Company effected a 240 thousand-for-1 forward split of issued and outstanding shares of common stock.
May 22, 2024	Board approved the issuance of warrants to AFMIC and adopted the 2024 Omnibus Incentive Plan.
May 23, 2024	Common stock began trading on the NYSE under the symbol BOW; Company completed its IPO.
May 28, 2024	Company issued to AFMIC warrants to purchase additional shares of the Company's common stock.
June 30, 2024	General partner of BIHL approved the valuation and the acceleration of unvested Class P Interests.
October 25, 2024	Secondary offering of common stock.
October 30, 2024	Dr. Ava Schnidman was elected to the board of directors and appointed to the Compensation, Nominating and Corporate Governance Committee.
December 1, 2024	Company exercised its option to extend the Chicago lease.
December 3, 2024	BIHL was dissolved.
February 21, 2025	The Board approved and adopted the Bowhead Specialty Holding Inc. Change in Control Severance Plan.
January 1, 2025	The quota share reinsurance treaty for Cyber generally renews.
May 1, 2025	The remainder of the company's reinsurance treaties renew.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.